- Home
- / San Rocco Therapeutics
San Rocco Therapeutics
San Rocco Therapeutics Summary
Company Summary
- Overview
- San Rocco Therapeutics (formerly known as Errant Gene Therapeutics (EGT) is a company developing treatments for life-threatening diseases recognized as rare disorders or orphan diseases. Its product candidates, Thalagen and CG-1521, target the treatment of the blood disorder thalassemia and refractory prostate cancer.
- Type
- Private
- Status
- Active
- Founded
- 2003
- HQ
- Chicago, IL, US | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
4 locations detected
Chicago, IL HQ
United States
Jefferson Fulton Building, 218 N Jefferson St #300
New York, NY
United States
228 Park Ave S #15
Los Angeles, CA
United States
Roma, Lazio
Italy
Via Livorno, 45
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026